Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Vassilios Dimopoulos

Neurological Surgery Amherst, NY Medical Doctor

NPI 1720099724 CMS profile 1313035

3980 Sheridan Dr Ste 200A, Amherst, NY 14226

Open in the dashboard

General payments

$6,851

88 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,120 paid to institutions, not to them · program year 2019

Through program year 2025, Vassilios Dimopoulos of Amherst, NY is reported in the CMS Open Payments database as having received $6,851 across 88 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,120 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 63rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,027 25
2024 General $1,782 22
2023 General $533 18
2022 General $1,169 17
2021 General $247 4
2020 General $93 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vassilios Dimopoulos
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Vassilios Dimopoulos were reported at $3,027. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Vassilios Dimopoulos Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $93 $294 $76–$2,174 $114
2021 $247 $387 $105–$2,432 $132
2022 $1,169 $542 $139–$2,989 $149
2023 $533 $534 $145–$2,697 $160
2024 $1,782 $574 $155–$3,046 $164
2025 $3,027 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Globus Medical, Inc. $2,752 19 payments
  2. Medical Device Business Services, Inc. $1,875 11 payments
  3. Arthrex, Inc. $366 5 payments
  4. Medtronic, Inc. $365 8 payments
  5. SI-BONE, Inc. $218 7 payments
  6. Intrinsic Therapeutics $213 1 payment
  7. DePuy Synthes Sales Inc. $183 3 payments
  8. GlaxoSmithKline, LLC. $170 3 payments
  9. Collegium Pharmaceutical, Inc. $149 8 payments
  10. SPR Therapeutics, Inc $61 1 payment
  11. Other $498 22 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $4,601 22 payments
  2. Food and Beverage $2,050 63 payments
  3. Education $200 3 payments
Products named General payments · program years 2020–2025
  1. EXCELSIUS GPS $2,166 15 payments
  2. Teligen $1,074 7 payments
  3. ELSA $506 3 payments
  4. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $213 1 payment
  5. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $213 1 payment
  6. O-ARM $213 3 payments
  7. BLENREP $170 3 payments
  8. XTAMPZA $149 8 payments
  9. IFUSE IMPLANT $140 3 payments
  10. CONDUIT $118 1 payment
  11. Other $738 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$28,849

Medicare's payments for the services billed

Medicare patients

55

Average age 70

Services billed

145

31 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Ischemic heart disease 33%
Diabetes 31%
Chronic kidney disease 31%
Heart failure 24%
COPD 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XTAMPZA
  • Collegium Pharmaceutical, Inc. $62
$62 — —
Gamunex-C
  • Grifols USA, LLC $32
$32 — —
VYEPTI
  • Lundbeck LLC $21
$21 — —
ZTLido
  • Scilex Pharmaceuticals Inc. $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

88 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record